10 Uploads

Newly developed compounds limit psychoactivity and cognitive impairment and may be especially useful for pediatric appli
Newly developed compounds limit psychoactivity and cognitive impairment and may be especially useful for pediatric appli
  • 81 vues
Vitality Biopharma Announces Proprietary THC Pharmaceutical with Greatly Decreased Psychoactivity
Vitality Biopharma Announces Proprietary THC Pharmaceutical with Greatly Decreased Psychoactivity
  • 48 vues
Vitality Biopharma Publishes Scientific Data on Discovery of Cannabinoid Glycosides
Vitality Biopharma Publishes Scientific Data on Discovery of Cannabinoid Glycosides
  • 48 vues
Vitality Biopharma Announces Proprietary THC Pharmaceutical with Greatly Decreased Psychoactivity
Vitality Biopharma Announces Proprietary THC Pharmaceutical with Greatly Decreased Psychoactivity
  • 60 vues
Vitality Biopharma Publishes Scientific Data on Discovery of Cannabinoid Glycosides
Vitality Biopharma Publishes Scientific Data on Discovery of Cannabinoid Glycosides
  • 81 vues
Vitality Biopharma Publishes Scientific Data on Discovery of Cannabinoid Glycosides
Vitality Biopharma Publishes Scientific Data on Discovery of Cannabinoid Glycosides
  • 88 vues
Vitality Biopharma Receives DEA Approval for Cannabinoid Pharma Development Facility
Vitality Biopharma Receives DEA Approval for Cannabinoid Pharma Development Facility
  • 74 vues
Approval of cannaboside pharmaceutical research included review by FDA and California Research Advisory Panel
Approval of cannaboside pharmaceutical research included review by FDA and California Research Advisory Panel
  • 61 vues
Vitality Biopharma
Vitality Biopharma
  • 77 vues
Vitality Biopharma V15
Vitality Biopharma V15
  • 55 vues